Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R L Schwartz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|February 16, 2005
Modafinil: new indications for wake promotionJonathan R L Schwartz
Drug Design, Development and Therapy|November 19, 2009
Modafinil in the treatment of excessive sleepinessJonathan R L Schwartz
The Journal of Clinical Psychiatry|December 4, 2004
Pharmacologic management of daytime sleepinessJonathan R L Schwartz
Drugs|December 22, 2006
Shift work sleep disorder: burden of illness and approaches to managementJonathan R L Schwartz, Thomas Roth
Current Neuropharmacology|July 10, 2009
Neurophysiology of sleep and wakefulness: basic science and clinical implicationsJonathan R L Schwartz, Thomas Roth
Neuropsychiatric Disease and Treatment|September 22, 2010
Armodafinil in the treatment of sleep/wake disordersJonathan R L Schwartz, Thomas Roth, Chris Drake
The Journal of Neuropsychiatry and Clinical Neurosciences|September 24, 2005
Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepinessJonathan R L Schwartz, Neil T Feldman, Richard K Bogan
Primary Care Companion to the Journal of Clinical Psychiatry|December 4, 2009
Recognition and management of excessive sleepiness in the primary care settingJonathan R L Schwartz, Thomas Roth, Max Hirshkowitz, et al.
Sleep Medicine|November 1, 2003
Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulantsJonathan R L Schwartz, Neil T Feldman, June M Fry, et al.
Psychopharmacology|April 24, 2003
Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategiesMichael J Thorpy, Jonathan R L Schwartz, Ruzica Kovacevic-Ristanovic, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|February 16, 2005
Modafinil: new indications for wake promotionJonathan R L Schwartz
Drug Design, Development and Therapy|November 19, 2009
Modafinil in the treatment of excessive sleepinessJonathan R L Schwartz
The Journal of Clinical Psychiatry|December 4, 2004
Pharmacologic management of daytime sleepinessJonathan R L Schwartz
Drugs|December 22, 2006
Shift work sleep disorder: burden of illness and approaches to managementJonathan R L Schwartz, Thomas Roth
Current Neuropharmacology|July 10, 2009
Neurophysiology of sleep and wakefulness: basic science and clinical implicationsJonathan R L Schwartz, Thomas Roth
Neuropsychiatric Disease and Treatment|September 22, 2010
Armodafinil in the treatment of sleep/wake disordersJonathan R L Schwartz, Thomas Roth, Chris Drake
The Journal of Neuropsychiatry and Clinical Neurosciences|September 24, 2005
Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepinessJonathan R L Schwartz, Neil T Feldman, Richard K Bogan
Primary Care Companion to the Journal of Clinical Psychiatry|December 4, 2009
Recognition and management of excessive sleepiness in the primary care settingJonathan R L Schwartz, Thomas Roth, Max Hirshkowitz, et al.
Sleep Medicine|November 1, 2003
Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulantsJonathan R L Schwartz, Neil T Feldman, June M Fry, et al.
Psychopharmacology|April 24, 2003
Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategiesMichael J Thorpy, Jonathan R L Schwartz, Ruzica Kovacevic-Ristanovic, et al.
Pageof 2